跳至主要内容
临床试验/EUCTR2022-003855-32-SE
EUCTR2022-003855-32-SE招募中1 期

An Interventional, Double-Blinded, 2-Arm Study to Investigate the Efficacy of Orally Administered Nirmatrelvir/Ritonavir Compared With Placebo/Ritanovir in Non-hospitalized Adult Participants suffering from post-COVID

Karolinska Institutet0 个研究点目标入组 400 人开始时间: 2023年1月31日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients, =18 years of age, diagnosed with post-acute COVID-19 syndrome, with reported EQ-5D-5L VAS<50
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 350
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • Acute COVID-19 infection, other non-related conditions with post-acute COVID-19 syndrome like symptoms, previous treatment with Paxlovid

研究者

相似试验